Wenxi Lib,
Yongchun Lia,
Pengchao Sund,
Nan Zhangac,
Yidan Zhaoa,
Shangshang Qin*a and
Yongxing Zhao*ac
aSchool of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450001, PR China. E-mail: zhaoyx@zzu.edu.cn; Fax: +86 0371 67739546; Tel: +86037167739165
bZhengzhou Traditional Chinese Hospital of Orthopaedics, Zhengzhou, Henan 450004, PR China
cKey Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, Zhengzhou, Henan 450001, PR China
dInstitute for Biological Interfaces 1, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany
First published on 29th April 2024
Correction for ‘Antimicrobial peptide-modified silver nanoparticles for enhancing the antibacterial efficacy’ by Wenxi Li et al., RSC Adv., 2020, 10, 38746–38754, https://doi.org/10.1039/D0RA05640E.
Accordingly, Fig. 1E, 2C, and 3D in the original article should be replaced with the following revised Fig. 1E, 2C, and 3D. The conclusions of the paper have not been affected.
Fig. 1E. Representative TEM images of AgNPs and MFP@AgNPs-1.
Fig. 2C. Morphology changes after treatment.
Fig. 3D. Representative images of histological analysis of the lung tissues.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |